[Hypervitaminosis D].
Excessive vitamin D causes marked and prolonged hypercalcemia by accelerating intestinal calcium absorption and bone resorption. Vitamin D induced hypercalcemia includes the toxic ingestion of excessive amount of vitamin D preparations, granulomatous diseases and lymphoproliferative malignancies. In vitamin D toxicity, the clinical courses vary depending on the vitamin D preparation responsible for the hypercalcemia. Hypercalcemia state continues for several months when D2 or D3 are responsible for the toxicity whereas the hypercalcemia would subside in a week when 1 alpha(OH) D3 or 1,25 (OH)2D3 are responsible for the toxicity. Abnormal calcium metabolism can be treated by hydration and glucocorticoids. Hypercalcemia is associated with variety kinds of granulomatous diseases, including sarcoidosis and tuberculosis. The granulomatous tissue is believed to be the site of the ectopic production of 1,25(OH)2D3 in which the regulation of the synthesis is quite different from that in the normal kidney. Glucocorticoid markedly diminishes the synthesis. Hypercalcemia associated with elevated serum 1.25(OH)2D3 levels is also found in patients with lymphomas and some other malignancies. However, there still are not sufficient evidences to prove that the excessive amount of endogenous 1.25(OH)2D3 is the primary cause of the hypercalcemia.
Morita
R
R
Dept. of Radiology, Shiga University of Medical Sciences.
Yamamoto
I
I
Takada
M
M
Ohnaka
Y
Y
Yuu
I
I
D015650:24,25-Dihydroxyvitamin D 3 / Q000096:biosynthesis; D000328:Adult; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D012507:Sarcoidosis / Q000150:complications; D014376:Tuberculosis / Q000150:complications; D014807:Vitamin D / Q000633:toxicity*
D014807:Vitamin D; D015650:24,25-Dihydroxyvitamin D 3